Cholesterol-lowering effect of a theaflavin-enriched green tea extract: A randomized controlled trial

Archives of Internal Medicine

Volumn 163, Issue 12, 2003, Pages 1448-1453

  Maron, David J ^a   Lu, Guo Ping ^b   Cai, Nai Sheng ^c   Wu, Zong Gui ^d   Li, Yue Hua ^e   Chen, Hui ^f   Zhu, Jian Qiu ^g   Jin, Xue Juan ^c   Wouters, Bert C ^h   Zhao, Jian ^h  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f Heart and Lung Hospital   (China)

^g First Foshan Hospital   (China)

^h Nashai Biotech LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; THEAFLAVIN; TRIACYLGLYCEROL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TEA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BIFLAVONOIDS; CATECHIN; CHOLESTEROL; CHOLESTEROL, LDL; DIET, FAT-RESTRICTED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PLANT EXTRACTS; TEA; TRIGLYCERIDES;

EID: 0038677965     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.12.1448     Document Type: Article

References (49)

1. Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002;13:41-49.
2. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342:1007-1011.
3. Hertog MG, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med. 1995;155:381-386.
4. Keli SO, Hertog MG, Feskens EJ, Kromhout D. Dietary flavonoids, antioxidant vitamins, and the incidence of stroke: the Zutphen Study. Arch Intern Med. 1996;156:637-642.
5. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk [letter]. Lancet. 1997;349:699.
6. Sesso HD, Gaziano JM, Buring JE, Hennekens CH. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol. 1999;149:162-167.
7. Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JC. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med. 1999;159:2170-2174.
8. Mukamal KJ, Maclure M, Muller JE, et al. Tea consumption and mortality after acute myocardial infarction. Circulation. 2002;105:2476-2481.
9. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? a meta-analysis. Am J Epidemiol. 2001;154:495-503.
10. Little JA, Shanoff HM, Cisma A, Yano R. Coffee and serum-lipids in coronary heart-disease. Lancet 1966;1:732-434.
11. Green MS, Jucha E. Association of serum lipids with coffee, tea, and egg consumption in free-living subjects. J Epidemiol Community Health. 1986;40:324-329.
12. Stensvold I, Tverdal A, Solvoll K, Foss OP. Tea consumption, relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med. 1992;21:546-553.
13. Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Green tea consumption and serum lipid profiles: a cross sectional study in northern Kyushu, Japan. Prev Med. 1992;21:526-531.
14. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ. 1995;310:693-696.
15. Akinyanju P, Yudkin J. Effect of coffee and tea on serum lipids in the rat. Nature. 1967;214:426-427.
16. Young W, Hotovec RL, Romero AG. Tea and atherosclerosis. Nature. 1967;216:1015-1016.
17. Yang TT, Koo MW. Hypocholesterolemic effects of Chinese tea. Pharmacol Res. 1997;35:505-512.
18. Vinson JA, Dabbagh YA. Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: mechanisms for the epidemiological benefits of tea drinking. FEBS Lett. 1998;433:44-46.
19. Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol. 1986;32:613-622.
20. Chan PT, Fong WP, Cheung YL, Huang Y, Ho WK, Chen ZY. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr. 1999;129:1094-1101.
21. Matsumoto N, Okushio K, Hara Y. Effect of black tea polyphenols on plasma lipids in cholesterol-fed rats. J Nutr Sci Vitaminol. 1998;44:337-342.
22. Ikeda I, Imasato Y, Sasaki E, et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta. 1992;1127:141-146.
23. Yang TT, Koo MW. Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci. 2000;66:411-423.
24. Bursill C, Roach PD, Bottema CD, Pal S. Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells. J Agric Food Chem. 2001;49:5639-5645.
25. Princen HM, van Duyvenvoorde W, Buytenhek R, et al. No effect of consumption of green and black tea on plasma lipid an antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol. 1998;18:833-841.
26. Bingham SA, Vorster H, Jerling JC, et al. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr. 1997;78:41-45.
27. van het Hof KH, de Boer HS, Wiseman SA, et al. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr. 1997;66:1125-32.
28. McAnlis GT, McEneny J, Pearce J, Young IS. Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr. 1998;52:202-206.
29. Duffy SJ, Vita JA, Holbrook M, Swerdloff PL, Keaney JF. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2001;21:1084-1089.
30. 21 CFR 210. Food and Drug Administration, Department of Health and Human Services. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; general. Revised April 1, 2002. Available at: http://www.access.gpo.gov/nara/cfr/waisidx_02/21cfr210_02.html. Accessed September 27, 2002.
31. 21 CFR 211. Food and Drug Administration, Department of Health and Human Services. Current good manufacturing practice for finished pharmaceuticals. Revised April 1, 2002. Available at: http://www.access.gpo.gov/nara/cfr/waisidx_02/21cfr211_02.html. Accessed September 27, 2002.
32. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
33. Wilson PW, Anderson KM, Castelli WP. Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham Offspring Study. Am J Med. 1991;90:11-16.
34. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
35. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infraction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
36. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
37. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA. 1998;279:1615-1622.
38. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339:1349-1357.
39. Sayama K, Lin S, Zheng G, Oguni I. Effects of green tea on growth, food utilization and lipid metabolism in mice. In Vivo. 2000;14:481-484.
40. Miura Y, Chiba T, Tomita I, et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001;131:27-32.
41. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med. 1996;125:384-389.
42. Serafini M, Ghiselli A, Ferro-Luzzo A. Red wine, tea, and antioxidants [letter]. Lancet. 1994;344:626.
43. Duffy SJ, Keaney JF, Holbrook M, et al. Short-and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001;104:151-156.
44. Geleijnse J, Witteman JC, Launer LJ, Lamberts SW, Pols HA. Tea and coronary heart disease: protection through estrogenlike activity? Arch Intern Med. 2000;160:3328-3329.
45. Loktionov A, Bingham SA, Vorster H, Jerling JC, Runswick SA, Cummings JH. Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br J Nutr. 1998;79:133-139.
46. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106:3143-3421
47. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2001.
48. Du S, Lu B, Zhai F, Popkin BM. A new stage of the nutrition transition in China. Public Health Nutr. 2002;5:169-174.
49. Tian H-G, Nan Y, Hu G, et al. Dietary survey in a Chinese population. Eur J Clin Nutr. 1995;49:26-32.